Skip to main content
SpringerLink
Log in

Abdominal Infections

  • Chapter
  • First Online:
Infections in the Adult Intensive Care Unit

  • 2061 Accesses

Abstract

Intra-abdominal infections are potentially life threatening and are a major cause of admission to the critical care area. Peritonitis is inflammation of the lining of the peritoneum, is usually due to a perforated viscus, and is often accompanied by the presence of pus. However, peritonitis may be classified as primary, secondary or tertiary [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pieracci FM, Barie PS. Management of severe sepsis of abdominal origin. Scand J Surg. 2007;96:184–96.

    PubMed  CAS  Google Scholar 

  2. Podnos YD, Jimenez JC, Wilson SE. Intra-abdominal sepsis in elderly persons. Clin Infect Dis. 2002;35:62–8.

    PubMed  Google Scholar 

  3. Van Erpecum KJ. Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis. Scand J Gastroenterol. 2006;41 Suppl 243:79–84.

    Google Scholar 

  4. Segarra-Newnham M, Henneman A. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding. Ann Pharmacother. 2010;44:1946–54.

    PubMed  CAS  Google Scholar 

  5. Marshall JC. Intra-abdominal infections. Microbes Infect. 2004;6:1015–25.

    PubMed  Google Scholar 

  6. Schecter WP, Ivatury RR, Rotondo MF, Hirshberg A. Open abdomen after trauma and abdominal sepsis: a strategy for management. J Am Coll Surg. 2006;203:390–6.

    PubMed  Google Scholar 

  7. Green BT, Tendler DA. Ischemic colitis: a clinical review. South Med J. 2005;98:217–22.

    PubMed  Google Scholar 

  8. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Disease Society of America. Clin Infect Dis. 2010;50:133–64.

    PubMed  Google Scholar 

  9. Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32:S513–26.

    PubMed  Google Scholar 

  10. Toorenvliet BR, Swank H, Schoones JW, Hamming JF, Bemelman WA. Laparoscopic peritoneal lavage for perforated colonic diverticulitis: a systematic review. Colorectal Dis. 2010;12:862–7.

    PubMed  CAS  Google Scholar 

  11. Solomkin JS, Mazuski J. Intra-abdominal sepsis: newer interventional and antimicrobial therapies. Infect Dis Clin North Am. 2009;23:593–608.

    PubMed  Google Scholar 

  12. Wong PF, Gilliam AD, Kumar S, Shenfine J, O’Dair GN, Leaper DJ. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults (review). Cochrane Database Syst Rev. 2005. doi:10.1002/14651848. CD 004539, p. 2.

  13. Strasberg SM. Acute calculous cholecystitis. N Engl J Med. 2008;358:2804–11.

    PubMed  CAS  Google Scholar 

  14. Julka K, Ko CW. Infectious diseases and the gallbladder. Infect Dis Clin North Am. 2010;24:885–98.

    PubMed  Google Scholar 

  15. Miura F, Takada T, Kawarada Y, et al. Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg. 2007;14:27–34.

    PubMed  Google Scholar 

  16. Yoshida M, Takada T, Kawarda Y, et al. Antimicrobial therapy for acute cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg. 2007;14:83–90.

    PubMed  Google Scholar 

  17. Theodorou P, Maurer CA, Spanholtz TA, et al. Acalculous cholecystitis in severly burned patients: incidence and predisposing factors. Burns. 2009;35:405–11.

    PubMed  CAS  Google Scholar 

  18. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Kelbsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005;100:322–31.

    PubMed  Google Scholar 

  19. Zerem E, Hadzic A. Sonographically guided percutaneous catheter drainage versus needle aspiration in the management of pyogenic liver abscess. Interv Radiol. 2007;189:W138–42.

    Google Scholar 

  20. Gupta K, Wu B. In the clinic acute pancreatitis. Ann Intern Med. 2010;153:51–5, quiz ITC516.

    Google Scholar 

  21. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101:2379–400.

    PubMed  Google Scholar 

  22. Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut. 2005;54 Suppl 3:1–9.

    Google Scholar 

  23. Nathens AB, Curtis JR, Beale RJ, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med. 2004;32:2524–36.

    PubMed  Google Scholar 

  24. Wu BU, Bakker OJ, Papachristou GI, et al. Blood urea nitrogen in the early assessment of acute pancreatitis: an international validation study. Arch Intern Med. 2011;171:669–76.

    PubMed  Google Scholar 

  25. Wu BU, Johannes RS, Sun X, et al. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57:1698–703.

    PubMed  CAS  Google Scholar 

  26. Ranson JH, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet. 1976;143:209–19.

    PubMed  CAS  Google Scholar 

  27. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65:337–41.

    PubMed  CAS  Google Scholar 

  28. Takeda K, Yokoe M, Takada T, et al. Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. J Hepatobiliary Pancreat Sci. 2010;17:37–44.

    PubMed  Google Scholar 

  29. de-Madaria E, Soler-Sala G, Lopez-Font I, et al. Update of the Atlanta classification of severity of acute pancreatitis: should a moderate category be included? Pancreatology. 2010;10:613–9.

    PubMed  CAS  Google Scholar 

  30. Papachristou GI, Muddana V, Yadav D, et al. Comparison of BISAP, Ranson’s, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol. 2010;105:435–41, quiz 442.

    PubMed  Google Scholar 

  31. Miller FH, Keppke AL, Dalal K, Ly JN, Kamler VA, Sica GT. MRI of pancreatitis and its complications: part 1, acute pancreatitis. AJR Am J Roentgenol. 2004;183:1637–44.

    PubMed  Google Scholar 

  32. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174:331–6.

    PubMed  CAS  Google Scholar 

  33. Viremouneix L, Monneuse O, Gautier G, et al. Prospective evaluation of nonenhanced MR imaging in acute pancreatitis. J Magn Reson Imaging. 2007;26:331–8.

    PubMed  Google Scholar 

  34. Petrov MS, Shanbhag S, Chakraborty M, et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010;139:813–20.

    PubMed  Google Scholar 

  35. Acute Pancreatitis Classification Working Group. Revision of the Atlanta classification of acute pancreatitis (3rd revision). 2008. www.pancreasclub.com/resources/AtlantaClassification.pdf. Accessed 4 June 2011.

  36. Mofidi R, Suttie SA, Patil PV, et al. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery. 2009;146:72–81.

    PubMed  Google Scholar 

  37. Yao L, Huang X, Li Y, et al. Prophylactic antibiotics reduce pancreatic necrosis in acute necrotizing pancreatitis: a meta-analysis of randomized trials. Dig Surg. 2010;27:442–9.

    PubMed  CAS  Google Scholar 

  38. Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010;CD002941.

    Google Scholar 

  39. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651–9.

    PubMed  Google Scholar 

  40. Zhang MM, Cheng JQ, Lu YR, et al. Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol. 2010;16:3970–8.

    PubMed  Google Scholar 

  41. American Gastroenterological Association (AGA) Institute on “Management of Acute Pancreatitis” Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute medical position statement on acute pancreatitis. Gastroenterology. 2007;132:2019–21.

    Google Scholar 

  42. Al-Omran M, Albalawi ZH, Tashkandi MF, et al. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev. 2010;CD002837.

    Google Scholar 

  43. Petrov MS, Loveday BP, Pylypchuk RD, et al. Systematic review and meta-analysis of enteral nutrition formulations in acute pancreatitis. Br J Surg. 2009;96:1243–52.

    PubMed  CAS  Google Scholar 

  44. Besselink MG, Verwer TJ, Schoenmaeckers EJ, et al. Timing of surgical intervention in necrotizing pancreatitis. Arch Surg. 2007;142:1194–201.

    PubMed  Google Scholar 

  45. Hartwig W, Maksan SM, Foitzik T, et al. Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg. 2002;6:481–7.

    PubMed  Google Scholar 

  46. Mier J, Leon EL, Castillo A, et al. Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg. 1997;173:71–5.

    PubMed  CAS  Google Scholar 

  47. Haas B, Nathens AB. Surgical indications in acute pancreatitis. Curr Opin Crit Care. 2010;16(2):153–8.

    PubMed  Google Scholar 

  48. Amano H, Takada T, Isaji S, et al. Therapeutic intervention and surgery of acute pancreatitis. J Hepatobiliary Pancreat Sci. 2010;17:53–9.

    PubMed  Google Scholar 

  49. van Santvoort HC, Besselink MG, Bakker OJ, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010;362:1491–502.

    PubMed  Google Scholar 

  50. Hugonnet S, Sax H, Eggimann P, et al. Nosocomial bloodstream infection and clinical sepsis. Emerg Infect Dis. 2004;10:76–81.

    PubMed  Google Scholar 

  51. Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40:643–54.

    PubMed  Google Scholar 

  52. Leone M, Garnier F, Antonini F, et al. Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Med. 2003;29:551–4.

    PubMed  Google Scholar 

  53. Gastmeier P, Behnke M, Schwab F, et al. Benchmarking of urinary tract infection rates: experiences from the intensive care unit component of the German national nosocomial infections surveillance system. J Hosp Infect. 2011;78:41–4.

    PubMed  CAS  Google Scholar 

  54. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37:783–805.

    PubMed  Google Scholar 

  55. Rosenthal VD, Maki DG, Jamulitrat S, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003–2008, issued June 2009. Am J Infect Control. 2010;38:95–104, e102.

    PubMed  Google Scholar 

  56. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.

    PubMed  Google Scholar 

  57. Saint S, Meddings JA, Calfee D, et al. Catheter-associated urinary tract infection and the Medicare rule changes. Ann Intern Med. 2009;150:877–84.

    PubMed  Google Scholar 

  58. Meddings J, Rogers MA, Macy M, et al. Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51:550–60.

    PubMed  Google Scholar 

  59. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–63.

    PubMed  Google Scholar 

  60. Tenke P, Kovacs B, Bjerklund Johansen TE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31 Suppl 1:S68–78.

    PubMed  CAS  Google Scholar 

  61. Chenoweth CE, Saint S. Urinary tract infections. Infect Dis Clin North Am. 2011;25:103–15.

    PubMed  Google Scholar 

  62. Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966;274:1155–61.

    PubMed  CAS  Google Scholar 

  63. Allepuz-Palau A, Rossello-Urgell J, Vaque-Rafart J, et al. Evolution of closed urinary drainage systems use and associated factors in Spanish hospitals. J Hosp Infect. 2004;57:332–8.

    PubMed  CAS  Google Scholar 

  64. Lanara V, Plati C, Paniara O, et al. The prevalence of urinary tract infection in patients related to type of drainage bag. Scand J Caring Sci. 1988;2:163–70.

    PubMed  CAS  Google Scholar 

  65. Platt R, Polk BF, Murdock B, et al. Reduction of mortality associated with nosocomial urinary tract infection. Lancet. 1983;1:893–7.

    PubMed  CAS  Google Scholar 

  66. Schumm K, Lam TBL. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2008; Issue 2. Art. No.: CD004013. doi: 10.1002/14651858.CD004013.pub3.

  67. Karchmer TB, Giannetta ET, Muto CA, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000;160:3294–8.

    PubMed  CAS  Google Scholar 

  68. Niel-Weise BS, van den Broek PJ. Antibiotic policies for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev. 2005;CD005428.

    Google Scholar 

  69. Leone M, Perrin AS, Granier I, et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med. 2007;33:726–9.

    PubMed  CAS  Google Scholar 

  70. Warren JW, Anthony WC, Hoopes JM, et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA. 1982;248:454–8.

    PubMed  CAS  Google Scholar 

  71. Sandock DS, Gothe BG, Bodner DR. Trimethoprim-sulfamethoxazole prophylaxis against urinary tract infection in the chronic spinal cord injury patient. Paraplegia. 1995;33:156–60.

    PubMed  CAS  Google Scholar 

  72. Harding GK, Nicolle LE, Ronald AR, et al. How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med. 1991;114:713–9.

    PubMed  CAS  Google Scholar 

  73. Pfefferkorn U, Lea S, Moldenhauer J, et al. Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infections: a prospective randomized trial. Ann Surg. 2009;249:573–5.

    PubMed  Google Scholar 

  74. Wazait HD, Patel HR, van der Meulen JH, et al. A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin. BJU Int. 2004;94:1048–50.

    PubMed  CAS  Google Scholar 

  75. Leibovici L, Paul M, Poznanski O, et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother. 1997;41:1127–33.

    PubMed  CAS  Google Scholar 

  76. Vidal L, Gafter-Gvili A, Borok S, et al. Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2007;60:247–57.

    PubMed  CAS  Google Scholar 

  77. Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol. 2000;164:1254–8.

    PubMed  CAS  Google Scholar 

  78. Alvarez-Lerma F, Nolla-Salas J, Leon C, et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med. 2003;29:1069–76.

    PubMed  Google Scholar 

  79. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33:177–86.

    PubMed  CAS  Google Scholar 

  80. Bougnoux ME, Kac G, Aegerter P, et al. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008;34:292–9.

    PubMed  Google Scholar 

  81. Binelli CA, Moretti ML, Assis RS, et al. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect. 2006;12:538–43.

    PubMed  CAS  Google Scholar 

  82. Jorda-Marcos R, Alvarez-Lerma F, Jurado M, et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses. 2007;50:302–10.

    PubMed  Google Scholar 

  83. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.

    PubMed  CAS  Google Scholar 

  84. Riddle DJ, Dubberke ER. Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am. 2009;23:727–43.

    PubMed  Google Scholar 

  85. Lawrence SJ, Puzniak LA, Shadel BN, et al. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007;28:123–30.

    PubMed  Google Scholar 

  86. Beaulieu M, Williamson D, Pichette G, et al. Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit. Infect Control Hosp Epidemiol. 2007;28:1305–7.

    PubMed  Google Scholar 

  87. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.

    PubMed  Google Scholar 

  88. Hsu J, Abad C, Dinh M, et al. Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence. Am J Gastroenterol. 2010;105:2327–39, quiz 2340.

    PubMed  CAS  Google Scholar 

  89. Boyce JM, Pittet D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51:1–45, quiz CE41–4.

    PubMed  Google Scholar 

  90. Marra AR, Edmond MB, Wenzel RP, et al. Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis. 2007;7:42.

    PubMed  Google Scholar 

  91. Bartlett JG. Clostridium difficile: progress and challenges. Ann N Y Acad Sci. 2010;1213:62–9.

    PubMed  Google Scholar 

  92. Peled N, Pitlik S, Samra Z, et al. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea. Infect Control Hosp Epidemiol. 2007;28:377–81.

    PubMed  Google Scholar 

  93. FDA. Proton-pump inhibitors (PPIs) – drug safety communication: Clostridium difficile-associated diarrhea (CDAD) can be associated with stomach acid drugs. 2012. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm290838.htm?source=govdelivery. Accessed date 13 Feb 2012.

  94. Hickson M, D’Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80.

    PubMed  Google Scholar 

  95. Bulusu M, Narayan S, Shetler K, et al. Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol. 2000;95:3137–41.

    PubMed  CAS  Google Scholar 

  96. Kenneally C, Rosini JM, Skrupky LP, et al. Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest. 2007;132:418–24.

    PubMed  Google Scholar 

  97. Zilberberg MD, Shorr AF, Micek ST, et al. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med. 2009;37:2583–9.

    PubMed  Google Scholar 

  98. Crobach MJ, Dekkers OM, Wilcox MH, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009;15:1053–66.

    PubMed  CAS  Google Scholar 

  99. Bartlett JG. Detection of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2010;31 Suppl 1:S35–7.

    PubMed  Google Scholar 

  100. Wilcox MH, Planche T, Fang FC, et al. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol. 2010;48:4347–53.

    PubMed  Google Scholar 

  101. Mullane KM, Miller MA, Weiss K, et al. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis. 2011;53:440–7.

    PubMed  CAS  Google Scholar 

  102. Louie T, Gerson M, Grimard D, et al. Results of a phase III trial comparing Tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhea (CDAD). In: ICAAC 2007: abstract no. K-425a. American Society of Microbiology, Washington, D.C.

    Google Scholar 

  103. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–7.

    PubMed  CAS  Google Scholar 

  104. Apisarnthanarak A, Razavi B, Mundy LM. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis. 2002;35:690–6.

    PubMed  Google Scholar 

  105. Nelson R. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2007;CD004610.

    Google Scholar 

  106. Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med. 1992;117:297–302.

    PubMed  CAS  Google Scholar 

  107. Lamontagne F, Labbe AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245:267–72.

    PubMed  Google Scholar 

  108. Byrn JC, Maun DC, Gingold DS, et al. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143:150–4, discussion 155.

    PubMed  Google Scholar 

  109. Pepin J, Vo TT, Boutros M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52:400–5.

    PubMed  Google Scholar 

  110. Sailhamer EA, Carson K, Chang Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144:433–9, discussion 439–40.

    PubMed  Google Scholar 

  111. Gerding DN, Johnson S. Management of Clostridium difficile infection: thinking inside and outside the box. Clin Infect Dis. 2010;51:1306–13.

    PubMed  Google Scholar 

  112. Herpers BL, Vlaminckx B, Burkhardt O, et al. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection. Clin Infect Dis. 2009;48:1732–5.

    PubMed  CAS  Google Scholar 

  113. Marrero J, Martinez FJ, Hyzy R. Update in nonpulmonary critical care. Advances in critical care hepatology. Am J Respir Crit Care Med. 2003;168:1421–6.

    PubMed  Google Scholar 

  114. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190–201.

    PubMed  Google Scholar 

  115. Perumalswami PV, Schiano TD. The management of hospitalised patients with cirrhosis: the Mount Sinai experience and a guide for hospitals. Dig Dis Sci. 2011;56:1266–81.

    PubMed  Google Scholar 

  116. Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol. 2010;16:3347–57.

    PubMed  CAS  Google Scholar 

  117. Gustot T, Durand F, Lebrec D, Vincent J-L, Moreau R. Severe sepsis in cirrhosis. Hepatology. 2009;50:2022–33.

    PubMed  CAS  Google Scholar 

  118. Lacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens RD, Sharshar T. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med. 2009;37:S331–6.

    Google Scholar 

  119. Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:727–38.

    PubMed  Google Scholar 

  120. Trotter JF. Practical management of acute liver failure in the intensive care unit. Curr Opin Crit Care. 2009;15:163–7.

    PubMed  Google Scholar 

  121. Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care. 2008;14:189–97.

    PubMed  Google Scholar 

  122. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26–42.

    PubMed  CAS  Google Scholar 

  123. Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Data Syst Rev; 2010. Issue 9. Art.No.: CD002907. doi:10.1002/14651858.CD002907.pub2.

  124. Koulaouzidis A, Bhat S, Saeed A. Spontaneous bacterial peritonitis. World J Gastroenterol. 2009;15:1042–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Beaumont Hospital The Royal College of Surgeons in Ireland, Dublin, Ireland

    Hilary Humphreys

  2. Queen’s Medical Centre University Hospital Nottingham, Nottingham, UK

    Bob Winter

  3. Rabin Medical Center Beilinson Hospital Unit of Infectious Diseases Sackler Faculty of Medicine Tel-Aviv University, Petach Tikva/Tel-Aviv, Israel

    Mical Paul

Authors
  1. Hilary Humphreys
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bob Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mical Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Humphreys, H., Winter, B., Paul, M. (2013). Abdominal Infections. In: Infections in the Adult Intensive Care Unit. Springer, London. https://doi.org/10.1007/978-1-4471-4318-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4318-5_8

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4317-8

  • Online ISBN: 978-1-4471-4318-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation